CTI BIOPHARMA CORP: accounts_receivable
| Value | {"amount": 2426000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2022-03-31) |
| Status | current |
| Entity | CTI BIOPHARMA CORP |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:57:46.154821+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/4b352e3e-7c51-446c-9c9f-81af9101ae02
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000891293-22-000026 · Open the official SEC filing →Retrieved: 2026-08-19T08:57:46.154821+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000891293/accounts-receivable/2022-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/4b352e3e-7c51-446c-9c9f-81af9101ae02
History
- no predecessors — first report